This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Yi Shi
Managing Partner at Lilly Asia Ventures


Yi Shi is the Founder and Managing Partner of Lilly Asia Ventures, a leading biomedical venture capital firm with focus on China. Prior to his current role, Yi worked at Eli Lilly and Company in business development licensing and corporate ventures. His education includes a Ph.D. in Biochemistry and a Master of Business Administration, both from Duke University. He also has a Bachelor of Sciences in Biology from the University of Science and Technology of China. His past and current Board memberships include: Betta Pharmaceuticals, Innovent Biologics, Chipscreen Biosciences, Transcenta, Ansun Biopharma, Elpiscience, and Terns Pharmaceuticals, etc.

Agenda Sessions

  • China Investment: Sunny days or gray skies ahead?


Speakers at this event